Tiroid ve Paratiroid Bezi Hastalıkları ile Psikiyatrik Bozukluklar
Özet
Bu çalışma, tiroid ve paratiroid bezi hastalıkları ile psikiyatrik bozukluklar arasındaki köklü ve karmaşık ilişkiyi incelemektedir. Santral sinir sistemini doğrudan etkileyen tiroid hormonlarındaki düzensizlikler; anksiyete, depresyon, bipolar bozukluk ve hatta psikoz gibi geniş bir yelpazede nöropsikiyatrik belirtilere yol açabilir. Hipotiroidi vakalarında bilişsel yavaşlama, unutkanlık ve depresif semptomlar ön plandayken, şiddetli durumlarda miksödem çılgınlığı ve Hashimoto ensefaliti gibi ağır tablolar görülebilir. Hipertiroidi ise metabolizmanın hızlanmasına bağlı olarak irritabilite, anksiyete atakları ve uyku bozuklukları ile karakterizedir; tirotoksikoz durumunda ise deliryum gelişebilir. Benzer şekilde paratiroid fonksiyon bozuklukları da kalsiyum dengesini bozarak hiperparatiroidide depresyon ve bilişsel defisite, hipoparatiroidide ise operasyon sonrası anksiyete ve duygudurum değişikliklerine neden olur. Diğer taraftan, lityum, trisiklik antidepresanlar ve bazı antipsikotikler gibi yaygın psikiyatrik ilaçların tiroid hormonu sentezini baskılayarak hipotiroidiyi ve kalsiyum duyarlı reseptörleri etkileyerek hiperparatiroidiyi tetiklediği bilinmektedir. Sonuç olarak, endokrin patolojilerin tedavisinde ve psikiyatrik hastalıkların tedavi direncini kırmada, hormonal aksların düzenli taranması ve multidisipliner bir yaklaşım hayati önem taşımaktadır.
This study examines the deep-rooted and complex relationship between thyroid/parathyroid gland disorders and psychiatric conditions. Thyroid hormones directly regulate central nervous system functions, and their imbalances lead to a wide spectrum of neuropsychiatric manifestations, including anxiety, depression, bipolar disorder, and psychosis. Hypothyroidism is predominantly associated with cognitive decline, forgetfulness, and depressive symptoms, while severe cases may manifest as myxedema madness or Hashimoto’s encephalopathy. Conversely, hyperthyroidism causes irritability, anxiety attacks, and sleep disturbances due to metabolic hyperactivity, with thyrotoxicosis potentially inducing delirium. Parathyroid dysfunctions similarly disrupt calcium homeostasis; hyperparathyroidism induces depression and cognitive deficits, whereas post-operative hypoparathyroidism frequently triggers anxiety and mood alterations. Furthermore, commonly prescribed psychotropic medications—such as lithium, tricyclic antidepressants, and certain antipsychotics—can adversely affect endocrine health by inhibiting thyroid hormone synthesis or inducing hyperparathyroidism via calcium-sensing receptor antagonism. Consequently, routine screening of endocrine axes and a multidisciplinary approach are highly critical both for managing underlying endocrinopathies and overcoming treatment resistance in psychiatric disorders.
Referanslar
Heinrich TW, Grahm G. Hypothyroidism Presenting as Psychosis: Myxedema Madness Revisited. Primary care companion to the Journal of clinical psychiatry. 2003 Dec;5(6):260–6.
Jain VK. Affective Disturbance in Hypothyroidism. British Journal of Psychiatry. 2018/01/29. 1971;119(550):279–80.
Moini J, Pereira K, Samsam M. Thyroid dysfunction and mental disorders. Epidemiology of Thyroid Disorders. 2020 Jan 1;191–206.
Hedden, Sarra L. Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration, Department of Heath & Human Services, 2015
Ord WM. Report of a committee of the Clinical Society of London nominated December 14, 1883, to investigate the subject of myxoedema. Trans Clin Soc Lond. 1888;21(Suppl).
Asher R. Myxoedematous Madness. British Medical Journal. 1949 Sep 10;2(4627):555.
Basraon S, Costantine MM. Mood Disorders in Pregnant Women With Thyroid Dysfunction. Clinical obstetrics and gynecology 2011;54.3: 506-514.
Hendrick V, Altshuler L, Whybrow P. Psychoneuroendocrinology Of Mood Disorders: The Hypothalamic-Pituitary-Thyroid Axis. Psychiatric Clinics of North America. 1998 Jun 1;21(2):277–92.
Lehrmann JA, Jain S. Myxedema psychosis with grade II hypothyroidism. General Hospital Psychiatry. 2002 Jul 1;24(4):275–7.
Heinrich TW, Grahm G. Hypothyroidism presenting as psychosis: myxedema madness revisited. Primary care companion to the Journal of Clinical Psychiatry. 2003;5(6):260.
Chari S. The lesson from a yellow psychotic patient. Hospital Medicine. 2002;63(6):370–1.
Bauer M, Glenn T, Pilhatsch M, Pfennig A, Whybrow PC. Gender differences in thyroid system function: relevance to bipolar disorder and its treatment. Bipolar disorders. 2014;16(1):58–71.
Nemeroff CB, Simon JS, Haggerty JJ, Evans DL. Antithyroid antibodies in depressed patients. The American journal of psychiatry. 1985;
Pies RW. Women, mood, and the thyroid. Women Psychiatry Health. 1995;4:4–10.
Mocellin R, Walterfang M, Velakoulis D. Hashimoto’s Encephalopathy Epidemiology, Pathogenesis and Management. 2007.
Chang KD, Keck Jr PE, Stanton SP, McElroy SL, Strakowski SM, Geracioti Jr TD. Differences in thyroid function between bipolar manic and mixed states. Biological psychiatry. 1998;43(10):730–3.
Krüger J, Kraschewski A, Jockers-Scherübl MC. Myxedema Madness–Systematic literature review of published case reports. General hospital psychiatry. 2021;72:102–16.
Haggerty JJ, Stern RA, Mason GA, Beckwith J, Morey CE, Prange AJ. Subclinical hypothyroidism: a modifiable risk factor for depression? The American journal of psychiatry. 1993;
Stern RA, Robinson B, Thorner AR, Arruda JE, Prohaska ML, Prange Jr AJ. A survey study of neuropsychiatric complaints in patients with Graves’ disease. Journal of Neuropsychiatry and Clinical Neurosciences. 1996;8(2):181–5.
de Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet . 2016/03/30. 2016 Aug 27;388:906–18.
Brandt F, Thvilum M, Almind D, Christensen K, Green A, Hegedüs L, et al. Hyperthyroidism and psychiatric morbidity: evidence from a Danish nationwide register study. Eur J Endocrinol. 2014;170(2):341–8.
Krishna VN, Thunga R, Unnikrishnan B, Kanchan T, Bukelo MJ, Mehta RK, et al. Association between bipolar affective disorder and thyroid dysfunction. Asian journal of psychiatry. 2013;6(1):42–5.
Fischer S, Ehlert U. Hypothalamic–pituitary–thyroid (HPT) axis functioning in anxiety disorders. A systematic review. Depression and anxiety. 2018;35(1):98–110.
Bunevicius R, Velickiene D, Prange AJ. Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves’ disease. General Hospital Psychiatry. 2005;27(2):133–9.
Trzepacz PT, McCue M, Klein I, Levey GS, Greenhouse J. A psychiatric and neuropsychological study of patients with untreated Graves’ disease. General hospital psychiatry. 1988;10(1):49–55.
Burch HB, Wartofsky L. Life-threatening thyrotoxicosis: thyroid storm. Endocrinology and metabolism clinics of North America. 1993;22(2):263–77.
Dubin WR, Weiss KJ, Zeccardi JA. Organic brain syndrome: The psychiatric imposter. JAMA. 1983;249(1):60–2.
Brownlie BE, Rae AM, Walshe JW, Wells JE. Psychoses associated with thyrotoxicosis-’thyrotoxic psychosis.’A report of 18 cases, with statistical analysis of incidence. European Journal of Endocrinology. 2000;142(5):438–44.
Parks KA, Parks CG, Onwuameze OE, Shrestha S. Psychiatric complications of primary hyperparathyroidism and mild hypercalcemia. American Journal of Psychiatry. 2017;174(7):620–2.
Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Postsurgical hypoparathyroidism—risk of fractures, psychiatric diseases, cancer, cataract, and infections. Journal of Bone and Mineral Research. 2014;29(11):2504–10.
Attia AS, Elnahla A, Hussein MH, Khadra HS, Lee GS, Toraih E, et al. Impact of psychiatric comorbidities on outcomes related to thyroid and parathyroid operations. In: Surgery (United States). Mosby Inc.; 2021. p. 209–19.
Sauvage MF, Marquet P, Rousseau A, Raby C, Buxeraud J, Lachâ Tre G. Relationship between Psychotropic Drugs and Thyroid Function: A Review Relationship Between Psychotropic Drugs and Thyroid Function: A Review. Vol. 149, Toxicol. Appl. Pharma-col. 1998.
Schou M, Amdisen A, Jensen SE, Olsen T. Occurrence of goitre during lithium treatment. Br Med J. 1968;3(5620):710–3.
Berens SC, Wolff J, Murphy DL. Lithium concentration by the thyroid. Endocrinology. 1970;87(5):1085–7.
Bauer M, Gitlin M. Adverse Effects of Lithium and Their Management. In: The Essential Guide to Lithium Treatment. Springer; 2016. p. 129–39.
Lazarus JH. Lithium and thyroid. Vol. 23, Best Practice and Research: Clinical Endocrinology and Metabolism. 2009. p. 723–33.
National Collaborating Centre for Mental Health (UK. “Bipolar disorder: the NICE guideline on the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care”. 2014
Bendz H, Sjödin I, Toss G, Berglund K. Hyperparathyroidism and long‐term lithium therapy–a cross‐sectional study and the effect of lithium withdrawal. Journal of internal medicine. 1996;240(6):357–65.
Saunders BD, Saunders EFH, Gauger PG. Lithium therapy and hyperparathyroidism: an evidence-based assessment. World journal of surgery. 2009;33(11):2314–23.
